Skip to main content
Equibles

BARCLAYS PLC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 312069 LONDON, X0
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,897,653
+$1,518,301 QoQ
Shares Held
107,670
+49.6% QoQ
Ownership
0.331%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. COLL ranks #14 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,302,737 $165,474,680
2 NBIX
Neurocrine Biosciences Inc
 324,807 $54,742,970
3 TEVA
Teva Pharmaceutical Industries Ltd
 1,343,554 $45,519,608
4 UTHR
UNITED THERAPEUTICS Corp
 72,010 $39,017,177
5 VTRS
Viatris Inc
 2,437,004 $38,699,622
6 INDV
Indivior Pharmaceuticals, Inc.
 907,024 $37,215,193
7 HIMS
Hims & Hers Health, Inc.
 861,006 $29,851,076
8 ALKS
Alkermes plc.
 219,935 $11,524,592

All Filings in COLL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,897,653 107,670
2026-03-31 $2,379,352 71,949
2025-12-31 $4,797,096 103,609
2025-09-30 $2,590,342 74,031
2025-06-30 $2,644,561 89,434
2025-03-31 $2,200,033 73,703
2024-12-31 $2,284,952 79,754
2024-09-30 $2,900,008 75,052
2024-06-30 $958,303 29,761
2024-03-31 $1,830,906 47,164
2023-12-31 $2,238,690 72,732
2023-09-30 $884,902 39,593
2023-06-30 $728,081 33,880
2023-03-31 $831,228 34,649
2022-12-31 $701,150 30,222
2022-09-30 $421,902 26,336
2022-06-30 $732,597 41,343
2022-03-31 $998,168 49,026
2021-12-31 $1,355,999 72,591
2021-09-30 $1,661,317 84,160
2021-06-30 $1,191,763 50,413
2021-03-31 $1,745,315 73,642
2020-12-31 $225,296 11,248
2020-09-30 $328,851 15,795
2020-06-30 $331,310 18,932
2020-03-31 $177,620 10,877